Last month’s performance of -2.87% for ProKidney Corp (PROK) is certainly impressive

ProKidney Corp (NASDAQ: PROK) on Monday, soared 11.92% from the previous trading day, before settling in for the closing price of $1.51. Within the past 52 weeks, PROK’s price has moved between $1.18 and $4.44.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The company achieved an average annual earnings per share of -2.23%. With a float of $92.13 million, this company’s outstanding shares have now reached $127.92 million.

The extent of productivity of a business whose workforce counts for 163 workers is very important to gauge. In terms of profitability, gross margin is 37.09%, operating margin of -3478.3%, and the pretax margin is -3028.15%.

ProKidney Corp (PROK) Insider and Institutional Ownership

Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of ProKidney Corp is 28.01%, while institutional ownership is 43.17%. The most recent insider transaction that took place on Sep 19 ’24, was worth 41,030. In this transaction Chief Regulatory Officer of this company sold 16,412 shares at a rate of $2.50, taking the stock ownership to the 103,480 shares. Before that another transaction happened on Sep 19 ’24, when Company’s Officer proposed sale 16,412 for $2.39, making the entire transaction worth $39,225.

ProKidney Corp (PROK) Latest Financial update

Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -2.23% per share during the next fiscal year.

ProKidney Corp (NASDAQ: PROK) Trading Performance Indicators

ProKidney Corp (PROK) is currently performing well based on its current performance indicators. A quick ratio of 17.09 was reported for the most recent quarter.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.56, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.42 in one year’s time.

Technical Analysis of ProKidney Corp (PROK)

The latest stats from [ProKidney Corp, PROK] show that its last 5-days average volume of 0.72 million was superior to 0.69 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 19.89%. Additionally, its Average True Range was 0.20.

During the past 100 days, ProKidney Corp’s (PROK) raw stochastic average was set at 24.43%, which indicates a significant decrease from 37.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 114.02% in the past 14 days, which was higher than the 103.23% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $1.8296, while its 200-day Moving Average is $2.2079. Now, the first resistance to watch is $1.7700. This is followed by the second major resistance level at $1.8500. The third major resistance level sits at $1.9800. If the price goes on to break the first support level at $1.5600, it is likely to go to the next support level at $1.4300. The third support level lies at $1.3500 if the price breaches the second support level.

ProKidney Corp (NASDAQ: PROK) Key Stats

Market capitalization of the company is 509.87 million based on 291,662K outstanding shares. Right now, sales total 0 K and income totals -35,470 K. The company made 0 K in profit during its latest quarter, and -17,910 K in sales during its previous quarter.